Clinical Study

Prognostic Significance of Immunohistochemical Phenotypes in Patients Treated for High-Grade Cervical Intraepithelial Neoplasia

Table 1

Positivity of immunohistochemical targets within the epithelium.

NEDREC
<5%>5%<5%>5%Fisher exactPhi

CD4+6 (27.3%)16 (72.7%)12 (100%)0 (0%)<0.0001−0.70
CD8+19 (86.4%)3 (13.6%)10 (83.3%)2 (16.7%)n.s.0.04
T-bet+4 (18.2%)18 (81.8%)12 (100%)0 (0%)<0.0001−0.78
GATA3+22 (100%)0 (0%)10 (83.3%)2 (16.7%)n.s.0.34
CD11c+11 (50%)11 (50%)10 (83.3%)2 (16.7%)n.s.0.22

NED: not evidence of disease; REC: recurrence of disease.